Dissemination Phenotypes after First-Line Immunotherapy in Metastatic NSCLC: Implications for Metastasis-Directed Therapy
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e698
DOI: 10.1016/j.ijrobp.2026.06.2167 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von A.R.R. Kawakibi und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kawakibi, A., Choudhury, N., Garassino, M., Bestvina, C., Chmura, S., Pitroda, S., & Juloori, A. (2026). Dissemination Phenotypes after First-Line Immunotherapy in Metastatic NSCLC: Implications for Metastasis-Directed Therapy. International Journal of Radiation Oncology*Biology*Physics, 126(1), e698. https://doi.org/10.1016/j.ijrobp.2026.06.2167
Vancouver
Kawakibi A, Choudhury N, Garassino M, Bestvina C, Chmura S, Pitroda S, et al. Dissemination Phenotypes after First-Line Immunotherapy in Metastatic NSCLC: Implications for Metastasis-Directed Therapy. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e698. doi:10.1016/j.ijrobp.2026.06.2167
BibTeX
@article{Kawakibi2026,
author = {Kawakibi, A.R.R. and Choudhury, N. and Garassino, M. and Bestvina, C.M. and Chmura, S.J. and Pitroda, S. and Juloori, A.},
title = {Dissemination Phenotypes after First-Line Immunotherapy in Metastatic NSCLC: Implications for Metastasis-Directed Therapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e698},
doi = {10.1016/j.ijrobp.2026.06.2167}
}
EUVIMED